Measurement of NAD+ metabolites in blood after oral intake of Vitamin B3
Phase 1
- Conditions
- /A
- Registration Number
- JPRN-jRCTs041190107
- Lead Sponsor
- Sato Tomohito
- Brief Summary
Oral intake of 500 mg nicotinamide raised blood NAD+ levels in healthy men
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 6
Inclusion Criteria
1. Healthy adults between ages of 20 years old and 80 years old
2. Those who gaven written consent to study
Exclusion Criteria
1. Current use of medications and supplements including Vitamin B3
2. Pregnancy
3. Lactation
4. Current use of medications
5. Any other conditions medical doctors find inadequate to participate in study
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Pharmacokinetics of NAD+ as the changed form of supplemented nicotinamide
- Secondary Outcome Measures
Name Time Method Pharmacokinetics of nicotinamide<br>Safety assessment mainly for liver functions